Fractyl Health vs QTREX Quantum
GUTS and QTEX side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How GUTS and QTEX compare
QTREX Quantum scores higher on the StockData Score (5 against 1 for Fractyl Health), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | GUTS | QTEX |
|---|---|---|
| Size and price | ||
| Market cap | $12.0M | – |
| Share price | $0.904 | $1.25 |
| Change, 1 year | −93.3% | 27.6% |
| Change, 5 years | – | −56.9% |
| Beta (5Y) | 1.67 | 2.55 |
| Employees | 100 | 30 |
| StockData Score | ||
| Total score | 1 | 5 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 0 |
| Performance score | 0 | 0 |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Profitability | ||
| Gross margin | – | 0.69% |
| Operating margin | – | −4714% |
| Net margin | – | −4574% |
| FCF margin | – | −3448% |
| Return on equity | – | −220% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Current ratio | 1.98 | 2.00 (better) |
| Altman Z-score | −16.16 | – |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 51.6% | 7.5% |
| Held by insiders | 66.1% | 27.8% |
| Insider net buying, 12 months | $187K (better) | −$218K |
| Short interest, % of float | 13.0% | 13.8% |
Go deeper
- GUTS stock overview
- GUTS income statement
- GUTS valuation and score
- QTEX stock overview
- QTEX income statement
- QTEX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.